This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Carlson, B L Articles by George, H Search for Related Content PubMed PubMed Citation Articles by Carlson, B L Articles by George, H

 Previous Article  |  Next Article 

J Clin Microbiol. 1987 October; 25(10): 1982-1984

Phadebact Monoclonal GC OMNI Test for confirmation of Neisseria gonorrhoeae.

Center for Laboratories and Communicable Disease Control, Massachusetts Department of Public Health, Jamaica Plain 02130.

ABSTRACT

The Phadebact Monoclonal GC OMNI Test (Pharmacia Diagnostics, Piscataway, N.J.) is used for the definitive identification of Neisseria gonorrhoeae. In this test, boiled organisms are examined by using a 1-min coagglutination technique. A total of 776 Neisseria strains, confirmed to the species level by patterns of acid production from carbohydrates incorporated in cysteine-tryptose agar or morphologically consistent with Neisseria meningitidis and fluorescent antibody negative, were tested by the coagglutination technique. Of the 516 isolates of N. gonorrhoeae, 8 (1.6%) were negative with the OMNI Test. Of the 260 isolates of Neisseria spp. other than N. gonorrhoeae, none showed a positive coagglutination reaction. The Phadebact Monoclonal GC OMNI Test provided rapid, accurate identification of N. gonorrhoeae (sensitivity, 98.4%; specificity, 100%).